Clinical trial • Phase I • Oncology
YL201 for Advanced solid tumors
Phase I trial of YL201 for Advanced solid tumors. 146 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 19-03-2025
- First CTIS Authorization Date
- 07-07-2025
Trial design
Phase I trial across 21 sites in France, Spain, Poland.
- Target Sample Size
- 146
Eligibility
Recruits 146 No vulnerable populations selected (isVulnerablePopulationSelected: false)..
- Vulnerable Population
- No vulnerable populations selected (isVulnerablePopulationSelected: false).
Recruitment
- Planned Sample Size
- 146
- Recruitment Window Months
- 35
Geography
- Total Number Of Sites
- 21
- Total Number Of Participants
- 115
France
- Earliest CTIS Part Ii Submission Date
- 02-06-2025
- Latest Decision Or Authorization Date
- 22-12-2025
- Processing Time Days
- 203
- Number Of Sites
- 8
- Number Of Participants
- 28
Sites
- Site Name
- Centre Hospitalier Universitaire De Bordeaux
- Department Name
- Department of Medical Oncology
- Contact Person Name
- Amaury DASTE
- Contact Person Email
- amaury.daste@chu-bordeaux.fr
- Site Name
- Institut De Cancerologie De L Ouest
- Department Name
- Medical Oncology
- Contact Person Name
- Sandrine HIRET
- Contact Person Email
- sandrine.hiret@ico.unicancer.fr
- Site Name
- Hospital Foch
- Department Name
- Services de Pneumologie & d’Oncologie Medicale
- Contact Person Name
- Alexandra BIZOT
- Contact Person Email
- a.bizot@hopital-foch.com
- Site Name
- Centr Georges Francois Leclerc
- Department Name
- Medical Oncology Department
- Contact Person Name
- Francois GHIRINGHELLI
- Contact Person Email
- fghiringhelli@cgfl.fr
- Site Name
- Centre Hospitalier Regional De Marseille
- Department Name
- CEPCM-CLIPP
- Contact Person Name
- Laurent GREILLIER
- Contact Person Email
- laurent.greillier@ap-hm.fr
- Site Name
- Institut Curie
- Department Name
- Department of Drug Development and Innovation (D3i)
- Contact Person Name
- Marie-Paule SABLIN
- Contact Person Email
- mariepaule.sablin@curie.fr
- Site Name
- Centre Hospitalier Universitaire De Poitiers
- Department Name
- Medical Oncology
- Contact Person Name
- Nicolas ISAMBERT
- Contact Person Email
- nicolas.isambert@chu-poitiers.fr
- Site Name
- Centre Hospitalier Universitaire De Nantes
- Department Name
- Departement Oncologie Medicale – Unite Oncologie Thoracique
- Contact Person Name
- Jeanne CHEN
- Contact Person Email
- jeanne.chen@chu-nantes.fr
Spain
- Earliest CTIS Part Ii Submission Date
- 26-06-2025
- Latest Decision Or Authorization Date
- 18-12-2025
- Processing Time Days
- 175
- Number Of Sites
- 11
- Number Of Participants
- 70
Sites
- Site Name
- Hospital Universitario Quironsalud Madrid
- Department Name
- Oncology
- Contact Person Name
- Valentina Boni
- Contact Person Email
- vboni@nextoncology.eu
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Oncology
- Contact Person Name
- Bernard Doger de Speville
- Contact Person Email
- bernard.doger@startmadrid.com
- Site Name
- Hospital Universitario Severo Ochoa
- Department Name
- Oncology
- Contact Person Name
- Ana Lopez Martin
- Contact Person Email
- almartin@salud.madrid.org
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Oncology
- Contact Person Name
- Juan Jose Soto Castillo
- Contact Person Email
- juanj.soto@startmadrid.com
- Site Name
- Hospital De La Santa Creu I Sant Pau
- Department Name
- Oncology
- Contact Person Name
- Georgia Anguera Palacios
- Contact Person Email
- ganguera@santpau.cat
- Site Name
- Hospital Clinico Universitario De Valencia
- Department Name
- Oncology
- Contact Person Name
- Andres Cervantes Ruiperez
- Contact Person Email
- andres.cervantes@uv.es
- Site Name
- Clinica Universidad De Navarra
- Department Name
- Oncology
- Contact Person Name
- Anna Vilalta-Lacarra
- Contact Person Email
- avilaltal@unav.es
- Site Name
- Hospital Quironsalud Barcelona
- Department Name
- Oncology
- Contact Person Name
- Fabricio Racca
- Contact Person Email
- fracca@nextoncology.eu
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Oncology
- Contact Person Name
- Jon Zugazagoitia Fraile
- Contact Person Email
- j.zugazagoitia.imas12@h12o.es
- Site Name
- Hospital Universitario Ramon Y Cajal
- Department Name
- Oncology
- Contact Person Name
- Federico Longo
- Contact Person Email
- fedelongomunoz@hotmail.com
- Site Name
- Clinica Universidad De Navarra (Pamplona)
- Department Name
- Oncology
- Contact Person Name
- Anna Vilalta-Lacarra
- Contact Person Email
- avilaltal@unav.es
Poland
- Earliest CTIS Part Ii Submission Date
- 26-06-2025
- Latest Decision Or Authorization Date
- 22-12-2025
- Processing Time Days
- 179
- Number Of Sites
- 2
- Number Of Participants
- 17
Sites
- Site Name
- Uniwersytecki Szpital Kliniczny W Poznaniu
- Department Name
- Oddzial Chemioterapii
- Contact Person Name
- Rodryg Ramlau
- Contact Person Email
- katedraonkologii@ump.edu.pl
- Site Name
- Europejskie Centrum Zdrowia Otwock Sp. z o.o.
- Department Name
- Oddzial Onkologii Klinicznej i Chemioterapii
- Contact Person Name
- Cezary Szczylik
- Contact Person Email
- cezary.szczylik@ecz-otwock.pl
Sponsor
Primary sponsor
- Full Name
- Medilink Therapeutics (Suzhou) Co. Ltd.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- China
Investigational products
- Investigational Product Name
- YL201
Related trials
Other published trials that may interest you.